glp-1 slows gastric emptying Nearly half of users discontinue within a year. Not because the medication “failed.” Often because the digestive adjustment wasn't supported. GLP-1s intentionally slow emptying. That shift changes motility patterns. If Clinical Consequences of Delayed Gastric

NICE guidance (NG28) recommends: HbA1c monitoring every 36 months until stable, then 6-monthly Renal function tests at least annually (more frequently if pre-existing kidney disease) Weight and BMI tracking to assess treatment response Blood pressure monitoring , as weight loss may allow reduction in antihypertensive medications Appropriate retinopathy screening for patients with diabetes, particularly those with pre-existing retinopathy taking semaglutide Communication with your healthcare team is vital

Antidiabetic drugs with limited evidence for tumor risk association -Glucosidase inhibitors As an antidiabetic drug, -glucosidase inhibitors primarily act by inhibiting the breakdown of complex carbohydrates in the gastrointestinal tract, thereby slowing their absorption and mitigating postprandial hyperglycemia

GLP-1 interacts with its receptor to stimulate islet -cells to secrete insulin, inhibit the release of glucagon by islet -cells, increase satiety, and delay gastric emptying in a glucose-dependent manner 284

Its improved technology helps in the removal of stretch marks and also promotes skin rejuvenation

This extraction process was carried out for a period of 3 h (26)